Zepp Health (ZEPP) Stock Price, News & Analysis

Company Overview

Zepp Health Corporation (NYSE: ZEPP) is a wearable technology company that develops smart health and fitness devices, along with digital platforms and services designed to help consumers monitor and improve their wellness. Its products collect and analyze information such as activity, sleep, heart rate and other health-related metrics.

The company’s principal consumer brand is Amazfit, which offers smartwatches, fitness trackers and related accessories. Zepp Health also operates the Zepp brand of digital health software and services and has introduced products and services focused on areas such as sleep and hearing health. Its technology platform supports device management, health insights, fitness tracking and personalized wellness features.

Zepp Health was founded in 2013 as Huami Corporation and adopted the Zepp Health name in 2021. The company has historically maintained a strategic relationship with Xiaomi, including developing and supplying certain Xiaomi-branded wearable products, while also building its own branded product portfolio. Zepp Health serves customers in international markets through online channels, retail partners and regional distribution networks. Wang Huang is the company’s founder and has served as its chairman and chief executive officer.

Key Stats

• Today's Range: $4.26 to $4.47
• 50-Day Range: $4.26 to $5.76
• 52-Week Range: $3.85 to $61.85
• Volume: 26,283 shs
• Average Volume: 47,604 shs
• Market Capitalization: $63.62 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $53.01
• Consensus Rating: Hold

Zepp Health Stock Analysis - MarketRank™

Zepp Health scored higher than 57% of companies evaluated by MarketBeat, and ranked 290th out of 473 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Hold

Consensus Rating

Zepp Health has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

Upside Potential

Zepp Health has a consensus price target of $53.01, representing about 1,123.1% upside from its current price of $4.33.

Amount of Analyst Coverage

Zepp Health has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Zepp Health is -1.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Zepp Health is -1.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Zepp Health has a P/B Ratio of 0.30. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.67% of the float of Zepp Health has been sold short.

Short Interest Ratio / Days to Cover

Zepp Health has a short interest ratio ("days to cover") of 7.31.

Change versus previous month

Short interest in Zepp Health has recently decreased by 9.12%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Zepp Health does not currently pay a dividend.

Dividend Growth

Zepp Health does not have a long track record of dividend growth.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: N/A

Search Interest

2 people have searched for ZEPP on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

MarketBeat Follows

1 people have added Zepp Health to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.1 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Zepp Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $45,344.00 in company stock.

Percentage Held by Insiders

36.00% of the stock of Zepp Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

52.61% of the stock of Zepp Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 5/19/2025
• Today: 9/22/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Discretionary
• Industry: Household Durables
• Sub-Industry: Consumer Electronics
• Current Symbol: NYSE:ZEPP
• CIK: 1720446
• Web: www.zepp.com
• Phone: 861059403268
• Fax: N/A
• Employees: 763
• Year Founded: 2012

Price Target and Rating

• Average Price Target for Zepp Health: $53.01
• High Price Target: $53.01
• Low Price Target: $53.01
• Potential Upside/Downside: +1,123.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.75)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$40.07 million
• Net Margins: -15.78%
• Pretax Margin: -14.01%
• Return on Equity: -19.64%
• Return on Assets: -7.18%

Debt

• Debt-to-Equity Ratio: 0.30
• Current Ratio: 0.90
• Quick Ratio: 0.70

Sales & Book Value

• Annual Sales: $258.90 million
• Price / Sales: 0.25
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $14.61 per share
• Price / Book: 0.30

Miscellaneous

• Outstanding Shares: 14,680,000
• Free Float: 9,395,000
• Market Cap: $63.62 million
• Optionable: Optionable
• Beta: 1.87